| CD73 promotes non-small cell lung cancer metastasis by regulating Axl signaling independent of GAS6. | CD73 promotes non-small cell lung cancer metastasis by regulating Axl signaling independent of GAS6.
Zhu J, Du W, Zeng Y, Liu T, Li J, Wang A, Li Y, Zhang W, Huang JA, Liu Z., Free PMC Article | 10/22/2024 |
| High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells. | High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells.
Giraulo C, Orlando L, Morretta E, Voli A, Plaitano P, Cicala C, Potaptschuk E, Müller CE, Tosco A, Monti MC, Morello S. | 08/3/2024 |
| Regulation of CD73 on NAD metabolism: Unravelling the interplay between tumour immunity and tumour metabolism. | Regulation of CD73 on NAD metabolism: Unravelling the interplay between tumour immunity and tumour metabolism.
Zhan J, Huang L, Niu L, Lu W, Sun C, Liu S, Ding Z, Li E., Free PMC Article | 08/2/2024 |
| The immunomodulatory ballet of tumour-derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD-L1 pathway in cancer. | The immunomodulatory ballet of tumour-derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD-L1 pathway in cancer.
Rubenich DS, Domagalski JL, Gentil GFS, Eichberger J, Fiedler M, Weber F, Federlin M, Poeck H, Reichert TE, Ettl T, Bauer RJ, Braganhol E, Schulz D., Free PMC Article | 07/26/2024 |
| ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis. | ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis.
Braganhol E, de Andrade GPB, Santos GT, Stefani MA., Free PMC Article | 06/28/2024 |
| CD73 as a T cell dysfunction marker predicting cardiovascular and infection events in patients undergoing hemodialysis. | CD73 as a T cell dysfunction marker predicting cardiovascular and infection events in patients undergoing hemodialysis.
Xiang F, Sun L, Cao X, Li Y, Chen X, Zhang Z, Zou J, Teng J, Shen B, Ding X. | 02/27/2024 |
| Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. | Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response.
Ortiz MA, Diaz-Torné C, De Agustin JJ, Estrada P, Reina D, Hernandez MV, Sang H, Zamora C, Cantó E, Corominas H, Vidal S., Free PMC Article | 02/6/2024 |
| Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73). | Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73).
Sosa-Luis SA, Ríos-Ríos WJ, Almaraz-Arreortua A, Romero-Tlalolini MA, Aguilar-Ruiz SR, Valle-Ríos R, Sánchez-Torres C, Torres-Aguilar H., Free PMC Article | 02/1/2024 |
| CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathway. | CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathway.
Hernandez KC, Shah AM, Lopez VA, Tagliabracci VS, Chen K, Xu L, Bassel-Duby R, Olson EN, Liu N., Free PMC Article | 01/29/2024 |
| The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency. | The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency.
Sperber HS, Raymond KA, Bouzidi MS, Ma T, Valdebenito S, Eugenin EA, Roan NR, Deeks SG, Winning S, Fandrey J, Schwarzer R, Pillai SK., Free PMC Article | 12/5/2023 |
| Effects of abnormal expression of CD73 on malignant phenotype of nasopharyngeal carcinoma. | Effects of abnormal expression of CD73 on malignant phenotype of nasopharyngeal carcinoma.
Jiang B, Tang M, Shi S, Xie H, Pan S, Zhang L, Sheng J. | 11/16/2023 |
| CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. | CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Samain R, Maiques O, Monger J, Lam H, Candido J, George S, Ferrari N, KohIhammer L, Lunetto S, Varela A, Orgaz JL, Vilardell F, Olsina JJ, Matias-Guiu X, Sarker D, Biddle A, Balkwill FR, Eyles J, Wilkinson RW, Kocher HM, Calvo F, Wells CM, Sanz-Moreno V., Free PMC Article | 10/30/2023 |
| Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma. | Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
Sun BY, Yang ZF, Wang ZT, Liu G, Zhou C, Zhou J, Fan J, Gan W, Yi Y, Qiu SJ., Free PMC Article | 10/26/2023 |
| 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells. | 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
Shi E, Wu Z, Karaoglan BS, Schwenk-Zieger S, Kranz G, Abdul Razak N, Reichel CA, Canis M, Baumeister P, Zeidler R, Gires O., Free PMC Article | 09/1/2023 |
| The CD73 is induced by TGF-beta1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma. | The CD73 is induced by TGF-β1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma.
Giraulo C, Turiello R, Orlando L, Leonardelli S, Landsberg J, Belvedere R, Rolshoven G, Müller CE, Hölzel M, Morello S. | 08/17/2023 |
| The Clinical Significance of CD73 in Cancer. | The Clinical Significance of CD73 in Cancer.
Bach N, Winzer R, Tolosa E, Fiedler W, Brauneck F., Free PMC Article | 08/3/2023 |
| The CD73 immune checkpoint promotes tumor cell metabolic fitness. | The CD73 immune checkpoint promotes tumor cell metabolic fitness.
Allard D, Cousineau I, Ma EH, Allard B, Bareche Y, Fleury H, Stagg J., Free PMC Article | 06/16/2023 |
| NT5E DNA methylation in papillary thyroid cancer: Novel opportunities for precision oncology. | NT5E DNA methylation in papillary thyroid cancer: Novel opportunities for precision oncology.
Bertoni APS, Valandro CF, Brasil RÁ, Zeiser FA, Wink MR, Furlanetto TW, da Costa CA. | 05/22/2023 |
| CD73 in glioblastoma: Where are we now and what are the future directions? | CD73 in glioblastoma: Where are we now and what are the future directions?
Gelsleichter NE, Azambuja JH, Rubenich DS, Braganhol E. | 05/8/2023 |
| Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer. | Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer.
Izawa M, Tanaka N, Murakami T, Anno T, Teranishi Y, Takamatsu K, Mikami S, Kakimi K, Imamura T, Matsumoto K, Oya M. | 04/26/2023 |
| CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. | CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
Faraoni EY, Singh K, Chandra V, Le Roux O, Dai Y, Sahin I, O'Brien BJ, Strickland LN, Li L, Vucic E, Warner AN, Pruski M, Clark T, Van Buren G, Thosani NC, Bynon JS, Wray CJ, Bar-Sagi D, Poulsen KL, Vornik LA, Savage MI, Sei S, Mohammed A, Zhao Z, Brown PH, Mills T, Eltzschig HK, McAllister F, Bailey-Lundberg JM., Free PMC Article | 04/6/2023 |
| AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression. | AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression.
Cheng HH, Hung-Ke L, Sheu ML, Lee CY, Tsai YC, Lai DW. | 03/28/2023 |
| The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy. | The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy.
Jiang X, Wu X, Xiao Y, Wang P, Zheng J, Wu X, Jin Z., Free PMC Article | 02/15/2023 |
| CD73/NT5E-mediated ubiquitination of AURKA regulates alcohol-related liver fibrosis via modulating hepatic stellate cell senescence. | CD73/NT5E-mediated ubiquitination of AURKA regulates alcohol-related liver fibrosis via modulating hepatic stellate cell senescence.
Liu Z, Wu B, Liu X, Wu X, Du J, Xia G, Cai J, Zhu H, Sheng X, Zhang M, Xu J, Xu T, Lv X., Free PMC Article | 02/14/2023 |
| Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. | Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity.
Fu Z, Chen S, Zhu Y, Zhang D, Xie P, Jiao Q, Chi J, Xu S, Xue Y, Lu X, Song X, Cristofanilli M, Gradishar WJ, Kalinsky K, Yin Y, Zhang B, Wan Y., Free PMC Article | 01/21/2023 |